mortality/aging
• median survival of mutants that only develop medulloblastoma is 114 days
|
neoplasm
• 30% of mutants develop other tumors, including hemangiosarcomas, intestinal tumors, rhabdomyosarcomas, and lymphomas
• however, no pituitary tumors are seen
|
• 66.7% of mutants develop medulloblastoma
• formation of medulloblastoma formation is accelerated compared to single Ptch1 heterozygotes or double heterozygotes
• medulloblastomas are less differentiated and more invasive than medulloblastomas from single Ptch1 heterozygotes
|
nervous system
• 66.7% of mutants develop medulloblastoma
• formation of medulloblastoma formation is accelerated compared to single Ptch1 heterozygotes or double heterozygotes
• medulloblastomas are less differentiated and more invasive than medulloblastomas from single Ptch1 heterozygotes
|
hydrocephaly
(
J:205254
)
• fraction of mutants develop hydrocephalus unrelated to tumor formation
|
• 1 month old cerebella show preneoplastic lesions in the outer molecular layer where progenitors within the external germinal layer previously resided, suggesting that medulloblastomas arise from granule neuron progenitors
|
muscle
digestive/alimentary system
Mouse Models of Human Disease |
DO ID | OMIM ID(s) | Ref(s) | |
medulloblastoma | DOID:0050902 |
OMIM:155255 |
J:205254 |